Under new CEO, Novo ends heart failure partnership with Japanese biotechnews2025-09-30T15:33:01+00:00September 30th, 2025|Endpoints News|
MFN updates: Trump drug price announcement on most favored nationnews2025-09-30T14:23:45+00:00September 30th, 2025|Endpoints News|
White House confirms Section 232 pharma investigation has resulted in 100% tariffs on some brand drugsnews2025-09-30T13:55:36+00:00September 30th, 2025|Endpoints News|
Metsera’s new obesity data create side effect and efficacy questions for Pfizer to answernews2025-09-30T11:31:58+00:00September 30th, 2025|Endpoints News|
GSK CEO Emma Walmsley on her exit, running the company and morenews2025-09-29T18:00:31+00:00September 29th, 2025|Endpoints News|
Genmab CEO on his yearslong interest in Merusnews2025-09-29T17:00:00+00:00September 29th, 2025|Endpoints News|
White House deadline brings flurry of pharma price cutdownsnews2025-09-29T16:20:56+00:00September 29th, 2025|Endpoints News|
Tourmaline attracted small bidding war before $1.4B sale to Novartisnews2025-09-29T14:32:55+00:00September 29th, 2025|Endpoints News|
Genmab to buy Merus for $8B, with multibillion-dollar plans in head and neck cancernews2025-09-29T10:52:41+00:00September 29th, 2025|Endpoints News|
GSK names new CEO as Luke Miels will take Emma Walmsley’s spot on Jan. 1news2025-09-29T10:38:17+00:00September 29th, 2025|Endpoints News|
